- $409.81m
- $252.30m
- $41.29m
- 56
- 24
- 66
- 47
REG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Grant of Options
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Result of AGM
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Publication of Annual Report
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Upcoming Investor Conferences
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Filing of Form 10-Q
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - First Quarter Financial Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Director/PDMR Shareholding
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of First Quarter 2023 Financial Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Director/PDMR Shareholding
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Appointment of Chief Financial Officer
Announcement